Observational Study of LUMRYZ in Narcolepsy

Active, not recruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Narcolepsy
Interventions
DRUG

LUMRYZ

Prescribed for narcolepsy in accordance with product label.

Trial Locations (12)

13057

Ghaly Sleep Management Services, East Syracuse

19001

Abington Neurological Associates, Abington

19096

Pulmonology Associates, Inc., Wynnewood

19610

Respiratory Specialists, Wyomissing

29201

Bogan Sleep Consultants, Columbia

34209

Jeremy D McConnell, MD PA, Bradenton

43017

Ohio Sleep Medicine Institute, Dublin

44106

University Hospitals Cleveland Medical Center, Cleveland

48823

Comprehensive Sleep Center, East Lansing

77375

Northwest Houston Neurology, Tomball

77478

Tricoastal Narcolepsy and Sleep Disorder Center, Sugar Land

07748

Patient First MD, Middletown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Avadel

INDUSTRY